Eton Pharmaceuticals (ETON) News Today $13.02 -0.49 (-3.63%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$13.01 -0.01 (-0.08%) As of 03/28/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Hillsdale Investment Management Inc. Invests $226,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Hillsdale Investment Management Inc. acquired a new stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 17,003 shares of the company's stock, valuedMarch 25, 2025 | marketbeat.comCROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency programMarch 25, 2025 | globenewswire.comHC Wainwright Analysts Lower Earnings Estimates for ETONMarch 23, 2025 | americanbankingnews.comResearch Analysts Set Expectations for ETON Q3 EarningsMarch 23, 2025 | americanbankingnews.comB. Riley Equities Analysts Raise Earnings Estimates for ETONEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Equities researchers at B. Riley increased their Q3 2025 earnings estimates for Eton Pharmaceuticals in a note issued to investors on Wednesday, March 19th. B. Riley analyst M. El-Saadi now anticipates that the company will post earnings peMarch 22, 2025 | marketbeat.comQ2 EPS Estimate for Eton Pharmaceuticals Lowered by AnalystEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Stock analysts at HC Wainwright cut their Q2 2025 earnings estimates for shares of Eton Pharmaceuticals in a research note issued to investors on Wednesday, March 19th. HC Wainwright analyst S. Ramakanth now anticipates that the company wilMarch 22, 2025 | marketbeat.comQ1 EPS Estimates for Eton Pharmaceuticals Lifted by B. RileyEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Equities researchers at B. Riley increased their Q1 2025 EPS estimates for Eton Pharmaceuticals in a report issued on Wednesday, March 19th. B. Riley analyst M. El-Saadi now expects that the company will post earnings of $0.06 per share forMarch 21, 2025 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Earns Buy Rating from HC WainwrightMarch 21, 2025 | americanbankingnews.comB. Riley Reiterates Buy Rating for Eton Pharmaceuticals (NASDAQ:ETON)March 21, 2025 | americanbankingnews.comB. Riley Analysts Increase Earnings Estimates for ETONMarch 21, 2025 | americanbankingnews.comEton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, Craig Hallum Analyst SaysCraig Hallum raised their price objective on shares of Eton Pharmaceuticals from $23.00 to $26.00 and gave the company a "buy" rating in a research note on Wednesday.March 20, 2025 | marketbeat.comEton Pharmaceuticals' (ETON) "Buy" Rating Reiterated at B. RileyB. Riley restated a "buy" rating and set a $24.00 price target (up from $21.00) on shares of Eton Pharmaceuticals in a research report on Wednesday.March 20, 2025 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Given Buy Rating at HC WainwrightHC Wainwright restated a "buy" rating and issued a $33.00 target price on shares of Eton Pharmaceuticals in a report on Wednesday.March 20, 2025 | marketbeat.comEton Pharmaceuticals price target raised to $26 from $23 at Craig-HallumMarch 19, 2025 | markets.businessinsider.comEton Pharmaceuticals price target raised to $24 from $21 at B. RileyMarch 19, 2025 | markets.businessinsider.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 18.0% in FebruaryEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 289,400 shares, a decrease of 18.0% from the February 13th total of 353,000 shares. Based on an average daily trading volume, of 263,000 shares, the days-to-cover ratio is presently 1.1 days. Approximately 1.3% of the company's shares are short sold.March 19, 2025 | marketbeat.com5 Analysts Assess Eton Pharmaceuticals: What You Need To KnowMarch 19, 2025 | benzinga.comEton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 19, 2025 | finance.yahoo.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | insidermonkey.comEton Pharmaceuticals (NASDAQ:ETON) Announces Quarterly Earnings ResultsEton Pharmaceuticals (NASDAQ:ETON - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.02). Eton Pharmaceuticals had a negative return on equity of 36.29% and a negative net margin of 15.81%.March 19, 2025 | marketbeat.comEton Pharmaceuticals reports Q4 EPS (2c), consensus 0cMarch 18, 2025 | markets.businessinsider.comEton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call TranscriptMarch 18, 2025 | seekingalpha.comEton Pharmaceuticals Reports Fourth Quarter 2024 Financial ResultsMarch 18, 2025 | globenewswire.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. grew its position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 230.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 214,878 shares of the comMarch 18, 2025 | marketbeat.comEton Pharmaceuticals reports ‘positive’ data from study of ET-600March 14, 2025 | markets.businessinsider.comEton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600March 14, 2025 | globenewswire.comEton Pharmaceuticals (ETON) to Release Earnings on ThursdayEton Pharmaceuticals (NASDAQ:ETON) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comOptime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®March 4, 2025 | globenewswire.comEton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025March 4, 2025 | globenewswire.comEton Pharmaceuticals announces commercial launch of Galzin capsulesMarch 3, 2025 | markets.businessinsider.comB.Riley Financial Sticks to Its Buy Rating for Eton Pharmaceuticals (ETON)March 3, 2025 | markets.businessinsider.comEton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) CapsulesMarch 3, 2025 | finance.yahoo.comEton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) CapsulesMarch 3, 2025 | globenewswire.com60,432 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by Anchor Capital Advisors LLCAnchor Capital Advisors LLC bought a new position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 60,432 shares of the company's stock,March 1, 2025 | marketbeat.comIronwood Pharma (IRWD) Has a New Rating from Craig-HallumFebruary 27, 2025 | markets.businessinsider.comAcuitas Investments LLC Lowers Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Acuitas Investments LLC reduced its holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 68.0% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 185,824 shares of the company's stock after selling 394,13February 18, 2025 | marketbeat.comEton secures US patent for diabetes insipidus treatmentFebruary 10, 2025 | finance.yahoo.comEton Pharmaceuticals granted new patent from USPTOFebruary 8, 2025 | markets.businessinsider.comEton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600February 7, 2025 | globenewswire.comCraig-Hallum Reaffirms Their Buy Rating on Eton Pharmaceuticals (ETON)February 6, 2025 | markets.businessinsider.comFDA extends target action date for Eton's ET-400February 6, 2025 | msn.comEton Pharmaceuticals: FDA extends PDUFA date for NDA for ET-400 to 5/28February 6, 2025 | markets.businessinsider.comEton Pharmaceuticals: FDA Extends ET-400 Review to Late MayFebruary 6, 2025 | marketwatch.comEton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400February 6, 2025 | globenewswire.comCraig-Hallum Sticks to Their Buy Rating for REPRO-MED Systems (KRMD)January 31, 2025 | markets.businessinsider.comBaader Bank Aktiengesellschaft Takes $373,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Baader Bank Aktiengesellschaft purchased a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 28,000 shares of the company's stock, valued at approxJanuary 31, 2025 | marketbeat.comIronwood Pharma (IRWD) Gets a Buy from Craig-HallumJanuary 30, 2025 | markets.businessinsider.comEton Pharmaceuticals Stock Hits All-Time High of $17.57January 28, 2025 | msn.comQ2 EPS Estimate for Eton Pharmaceuticals Raised by AnalystEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Research analysts at HC Wainwright boosted their Q2 2025 EPS estimates for Eton Pharmaceuticals in a note issued to investors on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings peJanuary 27, 2025 | marketbeat.comCraig-Hallum Remains a Buy on Eton Pharmaceuticals (ETON)January 25, 2025 | markets.businessinsider.com Remove Ads Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address ETON Media Mentions By Week ETON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETON News Sentiment▼0.440.82▲Average Medical News Sentiment ETON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETON Articles This Week▼43▲ETON Articles Average Week Remove Ads Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies WVE News IMCR News ANIP News DYN News INDV News AMPH News ETNB News ADPT News EVO News SPRY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETON) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ETON Stock Free ETON Stock Alerts